MedPath

SWOG

SWOG logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private, Subsidiary
Established
1956-01-01
Employees
101
Market Cap
-
Website
http://www.swog.org

S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer

Phase 2
Terminated
Conditions
Lung Cancer
Interventions
Biological: monoclonal antibody 11D10 anti-idiotype vaccine
Biological: monoclonal antibody GD2 anti-idiotype vaccine
Radiation: radiation therapy
First Posted Date
2003-01-27
Last Posted Date
2012-06-13
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
9
Registration Number
NCT00045617
Locations
πŸ‡ΊπŸ‡Έ

CCOP - Columbus, Columbus, Ohio, United States

πŸ‡ΊπŸ‡Έ

Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States

πŸ‡ΊπŸ‡Έ

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

and more 97 locations

SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer

Phase 3
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2017-04-17
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
3040
Registration Number
NCT00002651
Locations
πŸ‡¨πŸ‡¦

Saskatoon Cancer Centre at the University of Saskatchewan, Saskatoon, Saskatchewan, Canada

πŸ‡¨πŸ‡¦

McGill Cancer Centre at McGill University, Montreal, Quebec, Canada

πŸ‡¨πŸ‡¦

Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Ontario, Canada

and more 11 locations

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

Phase 2
Completed
Conditions
Leukemia
Myelodysplastic Syndromes
First Posted Date
2003-01-27
Last Posted Date
2015-03-06
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
130
Registration Number
NCT00016419
Locations
πŸ‡ΊπŸ‡Έ

MBCCOP - Gulf Coast, Mobile, Alabama, United States

πŸ‡ΊπŸ‡Έ

Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

and more 91 locations

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase 3
Terminated
Conditions
Bladder Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2017-06-08
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
521
Registration Number
NCT00005047
Locations
πŸ‡ΊπŸ‡Έ

Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, United States

πŸ‡ΊπŸ‡Έ

Feist-Weiller Cancer Center at Louisiana State University Health Sciences, Shreveport, Louisiana, United States

πŸ‡ΊπŸ‡Έ

William Beaumont Hospital - Royal Oak Campus, Royal Oak, Michigan, United States

and more 71 locations

S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer

Phase 2
Completed
Conditions
Peritoneal Cavity Cancer
Ovarian Cancer
Fallopian Tube Cancer
Interventions
Procedure: debulking surgery
First Posted Date
2003-01-27
Last Posted Date
2016-01-08
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
62
Registration Number
NCT00008138

S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma

Phase 3
Active, not recruiting
Conditions
Lymphoma
Interventions
First Posted Date
2003-01-27
Last Posted Date
2025-05-21
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
571
Registration Number
NCT00006721
Locations
πŸ‡ΊπŸ‡Έ

Northside Hospital Cancer Center, Atlanta, Georgia, United States

πŸ‡ΊπŸ‡Έ

Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States

πŸ‡ΊπŸ‡Έ

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States

and more 254 locations
Β© Copyright 2025. All Rights Reserved by MedPath